Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Dysphania Ambrosioides is a complex botanical-derived agent primarily utilized as a non-standardized plant allergenic extract and historically as an anthelmintic. It belongs to the Amaranthaceae family and is regulated for use in allergy testing and immunotherapy.
Name
Dysphania Ambrosioides
Raw Name
DYSPHANIA AMBROSIOIDES
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
13
Variant Count
20
Last Verified
February 17, 2026
About Dysphania Ambrosioides
Dysphania Ambrosioides is a complex botanical-derived agent primarily utilized as a non-standardized plant allergenic extract and historically as an anthelmintic. It belongs to the Amaranthaceae family and is regulated for use in allergy testing and immunotherapy.
Detailed information about Dysphania Ambrosioides
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Dysphania Ambrosioides.
Dysphania Ambrosioides, formerly known scientifically as Chenopodium ambrosioides and colloquially as Epazote or Mexican Tea, is a perennial herb native to Central America, South America, and southern Mexico. In the modern clinical landscape of 2026, it is primarily recognized within the pharmacological classification of Non-Standardized Plant Allergenic Extracts [EPC]. While it has deep historical roots in traditional medicine as an anthelmintic (a medication used to expel parasitic worms), its role in contemporary Western medicine is largely focused on diagnostic and therapeutic applications for allergic sensitivities.
Under the FDA’s regulatory framework, Dysphania Ambrosioides is categorized among various allergenic extracts used by clinicians to identify specific IgE-mediated hypersensitivities. It is important to distinguish between the raw botanical form, the concentrated essential oil (often called oil of chenopodium), and the standardized or non-standardized extracts used in clinical immunology. The drug class context provided by the FDA includes its association with other allergenic extracts, such as those for fungal, food, and animal hair allergens, reflecting its utility in comprehensive allergy panels.
Historically, the FDA recognized the active component of the plant, ascaridole, for its potent effects against intestinal parasites. However, due to a narrow therapeutic index (the margin between a safe dose and a toxic dose), its use as an oral anthelmintic has been largely superseded by safer synthetic alternatives like mebendazole or albendazole. In 2026, healthcare providers typically utilize this agent in a controlled clinical environment to manage or diagnose plant-based allergies.
The mechanism of action for Dysphania Ambrosioides varies significantly depending on its clinical application.
When used as an allergenic extract, the substance works by introducing specific proteins from the Dysphania plant to the patient's immune system. In diagnostic skin testing (prick or intradermal tests), the extract triggers a localized allergic response in sensitized individuals. This occurs when the plant's allergens bind to specific IgE antibodies located on the surface of mast cells. This binding causes 'degranulation,' the release of histamine and other inflammatory mediators, resulting in a 'wheal and flare' reaction (a raised, red bump). In immunotherapy (allergy shots), the mechanism involves the gradual desensitization of the immune system, shifting the body's response from an IgE-mediated inflammatory reaction to a more tolerant IgG4-mediated response.
At the molecular level, the primary active constituent is ascaridole, a monoterpene peroxide. Ascaridole is unique among natural products for its peroxide bridge. When ingested by parasites, this peroxide bridge undergoes reductive cleavage, generating free radicals. These highly reactive molecules cause oxidative stress and irreversible damage to the parasite's cellular membranes and metabolic pathways, leading to paralysis and death of the organism. Furthermore, the prompt identifies its role as an Adrenergic alpha-Agonist and beta-Agonist. This suggests that certain components of the extract may interact with adrenergic receptors, which are proteins on cell surfaces that respond to adrenaline (epinephrine). Alpha-adrenergic activity typically causes blood vessel constriction, while beta-adrenergic activity can influence heart rate and airway relaxation.
Understanding how the body processes Dysphania Ambrosioides is crucial for safety, particularly given the potential toxicity of its essential oil.
Dysphania Ambrosioides is available in several specialized preparations:
> Important: Only your healthcare provider can determine if Dysphania Ambrosioides is right for your specific condition. The use of botanical extracts requires precise dosing and professional supervision to avoid severe adverse reactions.
Dosage for Dysphania Ambrosioides is highly individualized, particularly when used as an allergenic extract. There is no 'one-size-fits-all' dose.
Dysphania Ambrosioides must be used with extreme caution in children.
Patients with impaired kidney function may experience decreased clearance of the metabolites of Dysphania Ambrosioides. While specific dose-adjustment scales (like those for creatinine clearance) do not exist for this extract, clinicians should exercise caution and potentially use lower starting doses in immunotherapy.
Because the liver metabolizes the active monoterpenes, patients with liver disease (e.g., cirrhosis or hepatitis) are at a significantly higher risk for systemic toxicity. Use in these patients requires a rigorous risk-benefit analysis.
Geriatric patients often have reduced physiological reserve and may be more susceptible to the adrenergic effects (increased heart rate or blood pressure) associated with this agent. Monitoring of cardiovascular parameters is recommended during administration.
In the context of immunotherapy, a missed dose can disrupt the desensitization process. If a dose is missed:
An overdose of Dysphania Ambrosioides, particularly the oral oil, is a medical emergency.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or frequency without medical guidance, as this increases the risk of life-threatening anaphylaxis.
When used as an allergenic extract for testing or therapy, local reactions are the most frequent occurrence. These typically include:
> Warning: Stop taking Dysphania Ambrosioides and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis:
Prolonged exposure to high doses of Dysphania Ambrosioides (specifically the oil) has been linked to chronic nephrotoxicity (kidney damage) and ototoxicity (permanent hearing loss). In the context of immunotherapy, long-term use is generally well-tolerated, but patients should be monitored for the development of new sensitivities or 'organ-shift' where allergic symptoms move from the nose to the lungs (asthma).
While Dysphania Ambrosioides extracts do not always carry a specific individual black box warning, all Allergenic Extracts as a class carry a stringent warning regarding Anaphylaxis.
Summary of Warning: Allergenic extracts can cause severe, life-threatening systemic reactions, including anaphylaxis. Patients must be observed for at least 30 minutes in a medical facility equipped with emergency supplies (including epinephrine) after every administration. Patients with severe or unstable asthma are at an increased risk for fatal reactions.
Report any unusual symptoms or side effects to your healthcare provider immediately to ensure your treatment plan remains safe.
Dysphania Ambrosioides is a potent pharmacological agent that requires careful handling. It contains ascaridole, a compound with a high potential for toxicity if not used according to strict clinical guidelines. Patients must be aware that botanical origin does not equate to safety; this substance can be lethal in doses only slightly higher than therapeutic levels.
No FDA black box warnings specifically for Dysphania Ambrosioides as a single entity exist, but it is governed by the class-wide warning for Allergenic Extracts. This warning mandates that the drug only be administered by clinicians trained in the management of anaphylaxis and that patients remain under observation for a minimum of 30 minutes post-injection. Epinephrine (1:1000) must be immediately available.
Patients undergoing long-term immunotherapy or those who have been exposed to high doses should undergo the following monitoring:
Following administration, some patients may experience dizziness or a 'systemic' feeling of malaise. It is recommended that patients wait at least 30 minutes after an injection before driving. If any dizziness or visual disturbances occur, do not operate heavy machinery.
Alcohol should be avoided on the day of administration. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of absorption of the extract and potentially mask the early signs of an allergic reaction or worsen hypotension during anaphylaxis.
If a patient experiences a systemic reaction, the healthcare provider will evaluate whether to continue treatment. In many cases, the dose is significantly reduced. If treatment is stopped entirely, there are no physical withdrawal symptoms, but the patient's original allergic symptoms will likely return.
> Important: Discuss all your medical conditions, especially respiratory and heart issues, with your healthcare provider before starting Dysphania Ambrosioides.
For each major interaction, the mechanism usually involves either the potentiation of the adrenergic system or the interference with the body's ability to respond to emergency treatment (epinephrine). The clinical consequence is either increased toxicity (cardiovascular or neurological) or reduced safety during an allergic emergency.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter allergy medications.
Dysphania Ambrosioides must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to other members of the Amaranthaceae or Chenopodiaceae families (such as Lamb’s Quarters or Spinach pollen) may exhibit cross-reactivity. Healthcare providers should perform a thorough 'cross-sensitivity' screening before initiating therapy.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and heart health, before prescribing or administering Dysphania Ambrosioides.
It is unknown if the active components of Dysphania Ambrosioides pass into breast milk. However, due to the potential for neurotoxicity and the sensitivity of the infant's developing nervous system, breastfeeding is generally discouraged if the mother is receiving high-dose therapy or has ingested the botanical form. The risk-benefit ratio must be discussed with a pediatrician.
In patients with a GFR below 60 mL/min/1.73m², the clearance of monoterpene metabolites is impaired. While no specific dose-adjustment formula exists, clinicians typically use the lowest possible concentration for testing and may extend the interval between immunotherapy injections.
Patients with Child-Pugh Class B or C hepatic impairment should avoid systemic exposure to Dysphania Ambrosioides. The liver's inability to process ascaridole significantly increases the risk of CNS toxicity and metabolic acidosis.
> Important: Special populations require individualized medical assessment and often more frequent monitoring of vital signs during treatment.
Dysphania Ambrosioides acts through two distinct pathways. As an Allergenic Extract, it facilitates IgE-mediated mast cell degranulation for diagnosis and induces T-regulatory cell production for therapy. At the molecular level, its active constituent, ascaridole, acts as a pro-oxidant. Upon entering a target cell (such as a parasite or a human neuron at high doses), the peroxide bond breaks, creating reactive oxygen species (ROS). These ROS attack unsaturated fatty acids in cell membranes, leading to lipid peroxidation and cellular death. Additionally, the extract functions as an Adrenergic alpha and beta-Agonist, directly stimulating receptors in the vascular and cardiac tissues.
| Parameter | Value |
|---|---|
| Bioavailability | High (Oral), Low (Subcutaneous) |
| Protein Binding | 60-80% (estimated) |
| Half-life | 4-6 hours (Ascaridole) |
| Tmax | 1-2 hours (Oral) |
| Metabolism | Hepatic (CYP-mediated) |
| Excretion | Renal (>70%), Pulmonary (trace) |
Dysphania Ambrosioides is classified as a Non-Standardized Plant Allergenic Extract. It is grouped with other botanical allergens and is distinct from standardized extracts (like Grass or Ragweed) because its potency is not measured by bioequivalent units but rather by weight/volume or protein nitrogen units.
Common questions about Dysphania Ambrosioides
In modern clinical practice, Dysphania Ambrosioides is primarily used as an allergenic extract for the diagnosis and treatment of specific plant-based allergies. Healthcare providers use it in skin prick tests to identify if a patient has an IgE-mediated sensitivity to the plant's proteins. Historically, it was a common treatment for intestinal parasites like roundworms, though this use has declined due to the availability of safer drugs. It is also used in small culinary amounts as a herb in Mexican cuisine, known as Epazote. However, its medicinal use must always be supervised by a professional due to its potential toxicity.
The most common side effects associated with Dysphania Ambrosioides extracts are local reactions at the site of injection or skin testing. These include redness, itching, and the formation of a raised bump or 'wheal,' which typically appears within minutes. Some patients may also experience mild headaches, nasal congestion, or fatigue following an immunotherapy session. If the plant is consumed in larger medicinal amounts, nausea and vomiting are common. Because it is an allergen, the most serious risk is a systemic allergic reaction, which requires immediate medical intervention.
It is strongly advised to avoid alcohol consumption on the days you receive Dysphania Ambrosioides injections or testing. Alcohol acts as a vasodilator, which can speed up the absorption of the allergen into your bloodstream, potentially increasing the risk of a severe systemic reaction. Furthermore, alcohol can mask early symptoms of anaphylaxis, such as lightheadedness or flushing, making it harder to identify an emergency. Alcohol may also worsen the drop in blood pressure if a serious allergic reaction occurs. Always wait at least 24 hours after your treatment before consuming alcoholic beverages.
Dysphania Ambrosioides is generally considered unsafe during pregnancy, particularly if ingested. The plant contains ascaridole and other compounds that are known abortifacients, meaning they can stimulate uterine contractions and lead to miscarriage or preterm labor. In the context of allergy shots (immunotherapy), most doctors will not start a new treatment plan during pregnancy because of the risk of anaphylaxis, which can deprive the fetus of oxygen. If you are already on a maintenance dose, your allergist will perform a strict risk-benefit analysis. Always inform your doctor immediately if you become pregnant while using this agent.
The timeframe for Dysphania Ambrosioides to 'work' depends on the goal of the treatment. For diagnostic skin testing, the results are almost immediate, with a reaction typically appearing within 15 to 20 minutes. If you are undergoing immunotherapy to reduce your allergies, the process is much slower, often taking 3 to 6 months of weekly injections to reach a maintenance level where symptoms begin to improve. Full effectiveness for allergy desensitization usually requires 3 to 5 years of consistent treatment. For its historical use against parasites, it typically worked within 24 hours of ingestion.
Yes, you can stop taking Dysphania Ambrosioides suddenly without experiencing physical withdrawal symptoms, as it is not a physically addictive substance. However, if you are undergoing immunotherapy for allergies, stopping the treatment prematurely will likely result in the return of your original allergy symptoms. If you miss several doses, you cannot simply resume at your previous dose because your risk of a severe allergic reaction increases. You must consult your allergist to determine a safe 'restart' dose. Never stop or change your schedule without discussing the clinical implications with your healthcare provider.
If you miss a scheduled dose of Dysphania Ambrosioides immunotherapy, contact your allergy clinic immediately for instructions. The protocol for a missed dose depends on how long it has been since your last injection. If it has only been a few days, you may be able to receive your regular dose. However, if several weeks have passed, your doctor will likely need to reduce the dose to ensure your safety and prevent a systemic reaction. Do not attempt to 'double up' on doses to make up for a missed one, as this significantly increases the risk of anaphylaxis.
There is currently no clinical evidence to suggest that Dysphania Ambrosioides causes weight gain. As an allergenic extract or a botanical agent, it does not significantly influence metabolic rate or appetite in the way that steroids or certain antidepressants might. Most side effects are localized to the immune system or the gastrointestinal tract. If you notice unexpected weight changes while on this medication, it is likely due to another factor or medication. You should discuss any significant changes in your weight or overall health with your healthcare provider for a thorough evaluation.
Dysphania Ambrosioides has several significant drug interactions that must be managed by a doctor. It should never be taken with beta-blockers, as these drugs interfere with the life-saving effects of epinephrine if an allergic emergency occurs. It also interacts with MAO inhibitors and other stimulants, which can lead to dangerously high blood pressure. Some antidepressants and even over-the-counter antihistamines can interfere with how your body responds to the drug or how your doctor interprets your test results. Always provide your healthcare team with a complete list of all medications and supplements you are currently taking.
Dysphania Ambrosioides is a botanical substance, and the extracts used in clinics are produced by various specialized laboratories rather than as 'brand-name' vs. 'generic' pills. These are typically referred to by their botanical name or as 'Epazote extract.' While different manufacturers may produce the extract, they are not always interchangeable because they are 'non-standardized,' meaning the protein concentration can vary between brands. Your allergist will usually stick with one manufacturer's extract for the duration of your treatment to ensure consistency and safety. Always check the label for the specific manufacturer information.